Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Short Review: Progress of Lipid-Lowering Therapies & Where are we Heading?
*Corresponding Author: Jan Albert Kuivenhoven, Department of Pediatrics, Section Molecular Genetics, University Medical Centre Groningen, University of Groningen,Warning: Undefined variable $university_str in /efsdata/omicsonline.org/httpdocs/includes/articles_utility.php on line 338
Warning: Undefined variable $university_str in /efsdata/omicsonline.org/httpdocs/includes/articles_utility.php on line 338
, 9713 Groningen, The Netherlands, Tel: +31-50-3637932, Email: j.a.kuivenhoven@umcg.nl
Received Date: Aug 07, 2020 / Accepted Date: Aug 31, 2020 / Published Date: Sep 07, 2020
Citation: van Zwol W, Lansberg PJ, Kuivenhoven JA (2020) Short Review: Progress of Lipid-Lowering Therapies, Where are we Heading? Atheroscler Open Access 5: 134.
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2020 van Zwol W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Times are exciting when it comes to numerous new treatment options for dyslipidaemia. Here, we provide a short update on the developments over the last year. While expectations are high, and affordability of new therapies are a concern, their ultimate application still largely depends proof of reduced morbidity and mortality from atherosclerotic cardiovascular disease.
